Skyhawk Therapeutics
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
35 Gatehouse Dr, Waltham, Massachusetts,...Phone Number
(617) 858-0041Website
www.skyhawktx.comRevenue
$9.5 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
2
About Skyhawk Therapeutics
Founded in 2015, Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression.Skyhawk Therapeutics is located in Massachusetts.Explore more
Skyhawk Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Skyhawk Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Skyhawk Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Skyhawk Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Skyhawk Therapeutics has new funding data
Product Launch: Get notified when Skyhawk Therapeutics launches new products
Skyhawk Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Skyhawk Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Skyhawk Therapeutics
Check if Skyhawk Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Skyhawk Therapeutics
Find 3 more new buyers
Compare Similar Companies to Skyhawk Therapeutics
Compare insights from companies similar to Skyhawk Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Skyhawk Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Skyhawk Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Skyhawk Therapeutics.
Skyhawk Therapeutics financials insights
Gather financial insights about Skyhawk Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Unspecified
$133M
Skyhawk Therapeutics Tech Stack
A closer look at the technologies used by Skyhawk Therapeutics
Most Recent Scoops
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Skyhawk Therapeutics News & Media
Skyhawk Therapeutics Releases Twelve-Month cUHDRS Subcomponent Results from its Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease
Twelve-month findings showed favorable and consistent trends for participants receiving SKY-0515 across all four cUHDRS subcomponents, including Total Functional Capacity (TFC), Total Motor Score (TMS), Symbol Digit Modalities Test (SDMT), and Stroop Word Reading Test (SWRT) Skyhawk also...Skyhawk Therapeutics Announces Twelve-Month Interim Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease
Twelve-month findings showed improvement in Composite Unified Huntington's Disease Rating Scale (cUHDRS) scores from baseline of +0.38, compared to an expected decline of -0.92 points in propensity score-weighted natural history analyses of symptomatic patients SKY-0515 patients achieved...Skyhawk Therapeutics Announces Twelve-Month Interim Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease
Twelve-month findings showed improvement in Composite Unified Huntington's Disease Rating Scale (cUHDRS) scores from baseline of +0.38, compared to an expected decline of -0.92 points in propensity score-weighted natural history analyses of symptomatic patients SKY-0515 patients achieved...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Skyhawk Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2015, Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression.Skyhawk Therapeutics is located in Massachusetts.... Read More
